Press Release: FDA accepts nirsevimab application as first protective option against RSV disease for all infants
FDA accepts nirsevimab application as first protective option against RSV disease for all infants Nirsevimab…
FDA accepts nirsevimab application as first protective option against RSV disease for all infants Nirsevimab…
GENOMICS | GENETICS | R&D | DIAGNOSIS TESTS Genomic Vision announces successful beta testing…
Home Cleaning provides all types of cleaning solutions for homes and office spaces. New York,…
WOBURN, Mass.–(BUSINESS WIRE)–Regulatory News: BALYO (FR0013258399, mnemonic: BALYO, PEA-PME eligible), a technology leader in the…
Internet City, Dubai–(Newsfile Corp. – January 4, 2023) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – January 4, 2023) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – January 4, 2023) – As a world class digital asset…
Bucharest, Romania–(Newsfile Corp. – January 4, 2023) – OnLaptop, a recognized leader in laptop repairs,…
TOKYO, Jan 5, 2023 – (JCN Newswire) – Mitsubishi Corporation and ENEOS Corporation are pleased…
Strategic partnership: Joint development of perception solutions and full-stack systems for advanced driver assistance and…
Intel (INTC), CBOE Global Markets (CBOE), Nu Holdings (NU), and Applied Blockchain (APLD) enter the…
IAC will run on the famed Monza F1 Circuit to push new boundaries in 2023…
Hong Kong, PRC, Jan 5, 2023 – (ACN Newswire) – China South City Holdings Limited…
NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical, a leading acquirer of medical office properties nationwide, has completed the…
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
Carlsbad, CA, Jan. 04, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical…
• Maximum Potential Dilution of Approximately 23.04%, Based on Share Capital of Cellectis as of…
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the…
ROCKVILLE, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the…